🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

CHRN CHRN

Company Profile ↓
$23.37
+610.33% 1Y
Mkt Cap$3.34B
P/E-4.76
P/B370.36
52W High$29.63
52W Low$2.98
Book Value$0.06
EPS (TTM)$-4.91

Company Overview

CHRN (CHRN) is a publicly traded company listed on with a market capitalization of $3.34B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 11.7% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $12.80M (-28.6% YoY); net profit $-11.70M.
  • Trailing 12 Months Year-on-year growth — revenue -28.6%.
  • 5-Year Trend Long-term compounding — revenue CAGR 11.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:11.74%
1 Year:-28.60%

Stock Price Performance

1 Year:+610.33%
6 Months:+157.66%
3 Months:+76.78%
1 Month:+33.39%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 77% of range
$2.98 $29.63
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)52.97 · Neutral
Price Performance
1M+33.39%
3M+76.78%
6M+157.66%
1Y+610.33%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 11.7% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-4.76
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$0.06
Price to Book
370.36
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
11.74%
Profit 5Y
-
Revenue (YoY)
-28.60%
Earnings (YoY)
-

Profitability & Returns

ROCE
-116.13%
ROE
-129.56%
ROA
-58.15%
Profit Margin
-91.37%
Op Margin
-
Gross Margin
53.48%
EPS (Latest Qtr)
$-2.04
EPS (TTM)
$-4.91

Balance Sheet & Liquidity

Debt/Equity
24.36
Quick Ratio
-
Current Ratio
0.74
Debt
$219.92M
Total Assets
$19.67M
Current Assets
$9.59M
Working Capital
$-2.23M

Ownership

Promoter Holding
97.57%
Chg in Prom Hold
-
FII / Inst Holding
1.19%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$12.80M
EBITDA
-
Free Cash Flow
$-11.99M
Operating Cash Flow
$-11.80M
Shares Outstanding
143.09M
Gross Margin
53.48%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ------------1.87M--2.52M2.97M-----------------------
Gross Profit 45.00K480.00K554.00K403.00K502.00K468.00K-194.00K1.50M203.00K403.00K843.00K352.00K396.00K544.00K777.00K767.00K967.00K1.08M1.60M1.56M1.75M637.00K1.26M1.81M1.24M1.29M1.81M1.21M1.64M1.69M2.00M2.25M2.46M1.95M2.64M2.21M1.81M819.00K2.55M1.07M
Operating Income -4.31M-3.73M--4.09M-5.63M-5.18M--6.64M-7.40M-6.87M--8.14M-8.46M-7.07M--8.61M-7.18M-6.09M-4.91M-5.10M-3.79M-4.78M-3.09M-2.42M-3.14M-3.35M-2.79M-4.24M-3.23M-3.65M-4.45M-4.28M-2.93M-3.26M-2.33M-2.64M-3.44M-3.98M-1.40M-5.62M
Net Income 56.13M12.02M-20.16M-4.12M-5.64M-5.18M-4.64M-3.65M-5.76M-8.48M-5.58M-8.30M-5.51M-6.33M-8.98M-7.90M-7.98M-6.98M-6.55M-3.07M206.00K-2.53M-11.77M2.45M-3.67M-1.27M-1.96M-4.62M-2.98M-4.30M-4.39M-4.23M-3.37M-3.43M-2.42M-2.07M-2.89M-2.71M-1.42M-6.88M
Diluted EPS -0.05-0.04-0.23--0.06-0.35--0.44-0.61-0.60-0.35-0.38--0.18--0.13--0.11--0.04--1.88-0.01-0.34-0.11-0.17-0.36-0.23-0.33-0.33-0.31-0.24-0.20-1.99-1.53-1.84-1.24-0.54-2.04
R&D Expense 699.00K1.10M-983.00K1.74M1.71M-2.15M2.22M2.22M-2.87M2.63M1.99M-1.81M1.39M1.28M1.38M1.50M1.15M711.00K452.00K599.00K603.00K709.00K618.00K921.00K873.00K887.00K1.15M1.40M1.16M1.14M1.12M777.00K988.00K852.00K550.00K583.00K

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2012Mar 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 2.71M03.30M5.33M8.66M14.22M7.35M11.33M13.92M8.88M11.25M12.91M18.28M17.93M12.80M
Gross Profit 370.00K-587.00K1.56M1.18M2.95M2.07M4.31M6.76M5.07M6.75M6.21M9.08M9.51M6.84M
Operating Income -14.24M-12.29K-10.29M-16.79M-21.56M-27.59M-31.61M-27.03M-16.64M-13.29M-13.83M-15.56M-15.11M-10.46M-13.33M
Net Income -15.04M-12.29K-11.89M-33.77M-19.59M-23.47M-29.12M-26.99M-12.13M-15.82M-9.76M-15.08M-15.20M-11.33M-11.70M
Diluted EPS ---0.57-3.02-1.83-2.05-0.82-0.44-2.53-2.21-0.88-1.16-1.10-8.43-4.91
R&D Expense 4.30M-2.68M3.87M6.48M8.88M9.48M5.85M4.60M2.47M2.55M3.63M5.03M3.87M3.03M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2011Jan 2012Mar 2012Dec 2012Mar 2013Dec 2013Jan 2014Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024May 2025Dec 2025
Total Assets --8.44K-29.18K6.58M-33.47M32.20M24.43M37.99M17.66M21.91M20.60M49.17M40.90M28.92M26.65M304.20M20.11M
Current Assets ------------------6.41M-
Cash & Equivalents 558.00K08.44K1.74M29.18K805.00K-25.19M19.55M16.85M27.81M7.66M10.87M12.86M40.41M20.52M8.64M4.49M2.40M1.17M
Inventory --------------------
Receivables ------------------3.79M-
Total Liabilities --8.10K-14.12K15.63M-10.67M23.39M17.89M16.60M14.93M15.12M16.16M11.95M15.46M16.31M13.95M228.05M11.08M
Current Liabilities -----12.05M-6.61M8.62M6.33M9.16M10.08M7.83M4.97M6.86M9.20M8.12M7.54M157.63M8.64M
Long Term Debt ---------6.79M4.83M2.65M407.00K1.99M1.99M---12.00M-
Total Debt ------------------219.92M-
Total Equity -10.42M-343-25.09M15.05K-36.37M-8.77M22.80M8.81M6.53M21.39M2.73M6.80M4.43M37.22M25.44M12.61M12.71M76.15M9.03M
Shares Outstanding ------------------143.09M-

Cash Flows (Annual)

Figures in USD.

Metric Dec 2012Mar 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024May 2025Dec 2025
Operating Cash Flow --11.99K---18.27M-25.00M-31.23M-22.16M-15.77M-8.76M-11.16M-14.69M-12.05M-9.85M-7.22M-11.80M
Investing Cash Flow -----1.49M-1.10M-456.00K-131.00K-60.00K0-59.00K-5.17M-157.00K-37.00K-1.38M-188.00K
Financing Cash Flow -32.72K--14.12M23.31M42.57M2.27M19.04M10.70M38.71M0348.00K7.77M11.00M6.63M
Capital Expenditure -830.00K--379.00K-1.49M-1.49M-1.10M-456.00K-131.00K-60.00K-0-59.00K-194.00K-157.00K-37.00K-1.38M-188.00K
Free Cash Flow -----19.76M-26.09M-31.68M-22.30M-15.83M-8.76M-11.21M-14.88M-12.21M-9.88M-8.60M-11.99M
Net Change in Cash --------------2.40M-

Ratios (Annual)

Figures in %.

Metric Dec 2012Mar 2013Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 13.7%-17.8%29.3%13.6%20.7%28.1%38.0%48.6%57.1%60.0%48.1%49.7%53.1%53.5%
Operating Margin % -526.3%--311.8%-315.3%-248.9%-194.0%-429.9%-238.5%-119.6%-149.6%-123.0%-120.5%-82.7%-58.4%-104.1%
Net Margin % -555.9%--360.0%-633.9%-226.2%-165.0%-396.1%-238.2%-87.2%-178.2%-86.8%-116.8%-83.1%-63.2%-91.4%
ROE % 60.0%-81.7%32.7%-148.1%-222.4%-359.4%-136.1%-989.4%-178.5%-356.9%-26.2%-59.3%-120.6%-89.2%-129.6%
ROCE % --188.2%-62.5%-91.4%-152.4%-109.7%-356.8%-118.1%-85.1%-32.7%-49.1%-72.7%-54.7%-116.1%

Shareholding Pattern

Insiders
97.57%
Institutions
1.19%
Public Float
48.83%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CHRN

Google News Sat, 13 Jun 2026

ChronoScale (CHRN) Stock Valuation After Sharp 1 Year Surge And Rich P/S Multiple - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOSDlhNmx2aVo5ajZyUlo3N1Q2XzlXWVJDWktqUEphNHhjY1RBZ3dSWFlhdWtaUEhpVTMyd2VHUHdfTFkwaXFZdm9kTGc0eEhqNHBhczVLcGh6dEFTOFZBUFNDQVAzWGJiX2w0OUttTkFuY2lfZlNTemVQbEN4ZlkyZC1HMHQzcjlpM1pLYl…

Google News ue, 05 May 2026

Applied Digital Completes Separation of Cloud Business, Establishing ChronoScale as Independent Public Company - Applied Digital Corporation (APLD)

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNcUlTSGNVNlM3d0VsQ3hZMmpJUzhhb1E4Y3FETHRvYVVOVlBHenVJcXVwYWhmRDdvM256UG1POXl1aTczUkM3bGprNFlWVFZlUkpRN1FHdUV3cVV4LWN4cFJqRFZHMXhYd3liRkhZMkFrMlVaN09TajRKN3Fzb1c3anFTU1RiQVBDTkRBRF…

Google News Wed, 06 May 2026

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE0taWhWdWo4X0gxbGo3aWdjaFM1Vmx3TlhpNGpBZGcxS0xMLS1ldF9CMTN4aGNEdDZZMU84RHFBVkNxSWNBVjNfZlVhSl9lZFFR?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>&nbsp;&nbsp;<fon…

Google News ue, 05 May 2026

CHRN Stock Price and Chart — NASDAQ:CHRN - TradingView

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBxSzdZYVN4ZkhsSDZROG5mcVVyUVRvdEF4NzlmRk53V1JJNkZScnRnWWs1emMwUW9SdTBxYnM0bUs2cERtUWJuLXJqWnhMUnJTUGhqdzZZVmx1cVM2?oc=5" target="_blank">CHRN Stock Price and Chart — NASDAQ:CHRN</a…

Google News hu, 07 May 2026

CHRN Stock Just Started Trading as Applied Digital Spins Off ChronoScale. How to Play Shares Here. - Barchart.com

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNTXZmM1NhcHdTMC1LZW92aUs2NHkzNHBLcnlkMHdQOTZNVG5SOWxQVE9WV2ppSmNiWmRVOVkzMmxYN1RlQkl0MHNFcHpiZnlzd2hfTmJmZDJlTGl2djVEc0RjSXNiS2lDWUU5Mk5WNzlUV0YxVGdDYzJlU3lsNFBrb18tSlFvMU9Qek1ydj…

Google News ue, 21 Jul 2026

ChronoScale (CHRN) Sees 10.7% Decline Amid Market Movements - GuruFocus

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQbkctZ2cwdHJtcEptUGd1eEZ6VHB1SXZNdGtyM0RYX0I3NHpkNE1jVzJLWllSbWJsQzVqSGNnUVhaNGVlVlNaMXZDUDk3RUpoNlE4bmZ4SUl0RF9ZU1NwVGROWHJZX1VPZVNVRkVlY3FGTDhieHV0R2JSQ19ISEYzSk9TN0kyNndhWlkzbT…

CHRN — Frequently Asked Questions

What is the current share price of CHRN?

As of 2026-08-05 17:25 PDT, CHRN trades at $23.37 on NASDAQ/NYSE. Its 52-week range is $2.98 to $29.63.

What is the market capitalisation of CHRN?

CHRN has a market capitalisation of $3.34B on NASDAQ/NYSE.

What is the P/E ratio of CHRN?

CHRN trades at a trailing price-to-earnings (P/E) ratio of -4.76. Its price-to-book (P/B) ratio is 370.36.

What is the return on equity (ROE) of CHRN?

CHRN has a return on equity (ROE) of -129.56%. Its return on capital employed (ROCE) is -116.13%.

Is CHRN a good stock to buy?

This page provides a data-driven analysis of CHRN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space